Globular adiponectin inhibits angiotensin II-induced nuclear factor κB activation through AMP-activated protein kinase in cardiac hypertrophy

Journal of Cellular Physiology

Volumn 222, Issue 1, 2010, Pages 149-155

  Wang, Cheng ^a   Li, Li ^a   Zhang, Zhi Guo ^a   Fan, Dong ^a   Zhu, Yi ^a   Wu, Li Ling ^a  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; ANGIOTENSIN II; ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA;

ADENOVIRUS; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DNA BINDING; DNA FLANKING REGION; HEART VENTRICLE HYPERTROPHY; MUSCLE CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; TRANSCRIPTION INITIATION;

ADIPONECTIN; AMP-ACTIVATED PROTEIN KINASES; ANGIOTENSIN II; ANIMALS; ATRIAL NATRIURETIC FACTOR; CARDIOMEGALY; ENZYME ACTIVATION; HEART VENTRICLES; HUMANS; I-KAPPA B PROTEINS; MYOCYTES, CARDIAC; NF-KAPPA B; PHOSPHORYLATION; RATS;

ADENOVIRIDAE; RATTUS;

EID: 73949144065     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.21931     Document Type: Article

References (39)

1. Ajuwon KM, Spurlock ME. 2005. Adiponectin inhibits LPS-induced NF-kappaB activation and IL-6 production and increases PPARgamma2 expression in adipocytes. Am J Physiol Regul Integr Comp Physiol 288:R1220-R1225.
2. Baeuerle PA, Baltimore D. 1996. NF-kappa B: Ten years after. Cell 87:13-20.
3. Bobbert P, Antoniak S, Schultheiss HP, Rauch U. 2008. Globular adiponectin but not fulllength adiponectin induces increased procoagulability in human endothelial cells. J Mol Cell Cardiol 44:388-394.
4. Cacicedo JM, YagihashiN, Keaney JF, Jr., Ruderman NB, Ido Y. 2004.AMPKinhibits fatty acidinduced increases in NF-kappaB transactivation in cultured human umbilical vein endothelial cells. Biochem Biophys Res Commun 324:1204-1209.
5. Chen H, Montagnani M, Funahashi T, Shimomura I, Quon MJ. 2003. Adiponectin stimulates production of nitric oxide in vascular endothelial cells. J Biol Chem 278:45021-45026.
6. Daimon M, Oizumi T, Saitoh T, KamedaW, Hirata A, Yamaguchi H, Ohnuma H, Igarashi M, Tominaga M, Kato T. 2003. Decreased serum levels of adiponectin are a risk factor for the progression to type 2 diabetes in the Japanese Population: The Funagata study. Diabetes Care 26:2015-2020.
7. Devaraj S, Torok N, Dasu MR, Samols D, Jialal I. 2008. Adiponectin decreases C-reactive protein synthesis and secretion from endothelial cells: Evidence for an adipose tissue-vascular loop. Arterioscler Thromb Vasc Biol 28:1368-1374.
8. Fang X, Palanivel R, Zhou X, Liu Y, Xu A, Wang Y, Sweeney G. 2005. Hyperglycemia- and hyperinsulinemia-induced alteration of adiponectin receptor expression and adiponectin effects in L6 myoblasts. J Mol Endocrinol 35:465-476.
9. Ferre P. 2004. Adiponectin: From adipocyte to skeletal muscle. Ann Endocrinol (Paris) 65:S36-S43.
10. Fruebis J, Tsao TS, Javorschi S, Ebbets-Reed D, Erickson MR, Yen FT, Bihain BE, Lodish HF. 2001. Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice. Proc Natl Acad Sci USA 98:2005-2010.
11. Fujioka D, Kawabata K, Saito Y, Kobayashi T, Nakamura T, Kodama Y, Takano H, Obata JE, Kitta Y, Umetani K, Kugiyama K. 2006. Role of adiponectin receptors in endothelininduced cellular hypertrophy in cultured cardiomyocytes and their expression in infarcted heart. Am J Physiol Heart Circ Physiol 290:H2409-H2416.
12. Grossmann ME, Nkhata KJ, Mizuno NK, Ray A, Cleary MP. 2008. Effects of adiponectin on breast cancer cell growth and signaling. Br J Cancer 98:370-379.
13. Hattori Y, Suzuki K, Hattori S, Kasai K. 2006. Metformin inhibits cytokine-induced nuclear factor kappaB activation via AMP-activated protein kinase activation in vascular endothelial cells. Hypertension 47:1183-1188.
14. Hattori Y, Hattori S, Akimoto K,Nishikimi T, Suzuki K,Matsuoka H, Kasai K. 2007. Globular adiponectin activates nuclear factor-kappaB and activating protein-1 and enhances angiotensin II-induced proliferation in cardiac fibroblasts. Diabetes 56:804-808.
15. Hirotani S, Otsu K, Nishida K, Higuchi Y, Morita T, Nakayama H, Yamaguchi O, Mano T, Matsumura Y, Ueno H, Tada M, Hori M. 2002. Involvement of nuclear factor-kappaB and apoptosis signal-regulating kinase 1 in G-protein-coupled receptor agonist-induced cardiomyocyte hypertrophy. Circulation 105:509-515.
16. Kalra D, Sivasubramanian N, Mann DL. 2002. Angiotensin II induces tumor necrosis factor biosynthesis in the adultmammalian heart through a protein kinase C-dependent pathway. Circulation 105:2198-2205.
17. Kemp BE, Mitchelhill KI, Stapleton D, Michell BJ, Chen ZP, Witters LA. 1999. Dealing with energy demand: The AMP-activated protein kinase. Trends Biochem Sci 24:22-25.
18. Kobayashi H, Ouchi N, Kihara S, Walsh K, Kumada M, Abe Y, Funahashi T, Matsuzawa Y. 2004. Selective suppression of endothelial cell apoptosis by the high molecular weight form of adiponectin. Circ Res 94:e27-e31.
19. Li HL, Wang AB, Huang Y, Liu DP, Wei C,Williams GM, Zhang CN, Liu G, Liu YQ, Hao DL, Hui RT, Lin M, Liang CC. 2005. Isorhapontigenin, a new resveratrol analog, attenuates cardiac hypertrophy via blocking signaling transduction pathways. Free Radic Biol Med 38:243-257.
20. Li L, Wu L, Wang C, Liu L, Zhao Y. 2007. Adiponectin modulates carnitine palmitoyltransferase-1 through AMPK signaling cascade in rat cardiomyocytes. Regul Pept 139:72-79.
21. Makino N, Sugano M, Satoh S, Oyama J, Maeda T. 2006. Peroxisome proliferator-activated receptor-gamma ligands attenuate brain natriuretic peptide production and affect remodeling in cardiac fibroblasts in reoxygenation after hypoxia. Cell Biochem Biophys 44:65-71.
22. Mistry T, Digby JE, Desai KM, Randeva HS. 2008. Leptin and adiponectin interact in the regulation of prostate cancer cell growth via modulation of p53 and bcl-2 expression. BJU Int 101:1317-1322.
23. Motobayashi Y, Izawa-Ishizawa Y, Ishizawa K,Orino S, Yamaguchi K, Kawazoe K, Hamano S, Tsuchiya K, Tomita S, Tamaki T. 2009. Adiponectin inhibits insulin-like growth factor-1-induced cell migration by the suppression of extracellular signal-regulated kinase 1/2 activation, but not Akt in vascular smooth muscle cells. Hypertens Res 32:188-193.
24. Ogunwobi OO, Beales IL. 2008. Globular adiponectin, acting via adiponectin receptor-1, inhibits leptin-stimulated oesophageal adenocarcinoma cell proliferation. Mol Cell Endocrinol 285:43-50.
25. Onohara N, Nishida M, Inoue R, Kobayashi H, Sumimoto H, Sato Y, Mori Y,Nagao T, Kurose H. 2006. TRPC3 and TRPC6 are essential for angiotensin II-induced cardiac hypertrophy. EMBO J 25:5305-5316.
26. Ouchi N, Kihara S, Arita Y, Okamoto Y,Maeda K, Kuriyama H, Hotta K, Nishida M, Takahashi M, Muraguchi M, Ohmoto Y, Nakamura T, Yamashita S, Funahashi T, Matsuzawa Y. 2000. Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-kappaB signaling through a cAMP-dependent pathway. Circulation 102:1296-1301.
27. Planavila A, Laguna JC, Vazquez-Carrera M. 2005. Atorvastatin improves peroxisome proliferator-activated receptor signaling in cardiac hypertrophy by preventing nuclear factor-kappa B activation. Biochim Biophys Acta 1687:76-83.
28. Purcell NH, Molkentin JD. 2003. Is nuclear factor kappaB an attractive therapeutic target for treating cardiac hypertrophy? Circulation 108:638-640.
29. Purcell NH, Tang G, Yu C, Mercurio F, DiDonato JA, Lin A. 2001. Activation ofNF-kappa B is required for hypertrophic growth of primary rat neonatal ventricular cardiomyocytes. Proc Natl Acad Sci USA 98:6668-6673.
30. Sheng L, Ye P, Liu YX, Han CG, Zhang ZY. 2008. Peroxisome proliferator-activated receptor beta/delta activation improves angiotensin II-induced cardiac hypertrophy in vitro.Clin Exp Hypertens 30:109-119.
31. Shibata R, Ouchi N, Ito M, Kihara S, Shiojima I, Pimentel DR, Kumada M, Sato K, Schiekofer S, Ohashi K, Funahashi T, Colucci WS, Walsh K. 2004. Adiponectin-mediated modulation of hypertrophic signals in the heart. Nat Med 10:1384-1389.
32. Shibata R, Sato K, Pimentel DR, Takemura Y, Kihara S, Ohashi K, Funahashi T, Ouchi N, Walsh K. 2005. Adiponectin protects against myocardial ischemia-reperfusion injury through AMPK- and COX-2-dependent mechanisms. Nat Med 11:1096-1103.
33. Shibata R, Izumiya Y, Sato K, PapanicolaouK, Kihara S, ColucciWS, Sam F, Ouchi N, Walsh K. 2007. Adiponectin protects against the development of systolic dysfunction following myocardial infarction. J Mol Cell Cardiol 42:1065-1074.
34. Siwik DA, Brown RD. 1996. Regulation of protein synthesis by alpha 1-adrenergic receptor subtypes in cultured rabbit aortic vascular smooth muscle cells. J Cardiovasc Pharmacol 27:508-518.
35. SunW, Lee TS, Zhu M, Gu C, Wang Y, Zhu Y, Shyy JY. 2006. Statins activate AMP-activated protein kinase in vitro and in vivo. Circulation 114:2655-2662.
36. Tang CH, Chiu YC, Tan TW, Yang RS, Fu WM. 2007. Adiponectin enhances IL-6 production in human synovial fibroblast via an AdipoR1 receptor, AMPK, p38, and NF-kappa B pathway. J Immunol 179:5483-5492.
37. Tomizawa A, Hattori Y, Kasai K, Nakano Y. 2008. Adiponectin induces NF-kappaB activation that leads to suppression of cytokine-induced NF-kappaB activation in vascular endothelialcells: Globular adiponectin vs. high molecular weight adiponectin. Diab Vasc DisRes 5:123-127.
38. Yoon MJ, Lee GY, Chung JJ, Ahn YH, Hong SH, Kim JB. 2006. Adiponectin increases fatty acid oxidation in skeletal muscle cells by sequential activation of AMP-activated protein kinase, p38 mitogen-activated protein kinase, and peroxisome proliferator-activated receptor alpha. Diabetes 55:2562-2570.
39. Zhang Y, Lee TS, Kolb EM, Sun K, Lu X, Sladek FM, Kassab GS, Garland T, Jr., Shyy JY. 2006. AMP-activated protein kinase is involved in endothelialNOsynthase activation in response to shear stress. Arterioscler Thromb Vasc Biol 26:1281-1287.